Delivery Order SPE2DB22D3501-SPE2DB25FUT59
Award Date
3/3/25
Potential Completion Date
3/4/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,040.41 firm fixed price delivery order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a specialty medication. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,359.98, is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 60ML, a pharmaceutical product, with a completion date of December 13, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,850.42 Firm Fixed Price Delivery Order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 120ML, a specialty medication. The contract has an ultimate completion date of October 25, 2024. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award, valued at $1,631.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This single-award IDC, valued at up to $999,999,999.00 through December 31, 2025, serves as the primary...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,298.59 Firm Fixed Price Delivery Order contract is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 180ML, a prescription medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,834.20 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $2,894.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a prescription medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,412.69 firm fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $1,183.92 firm-fixed-price delivery order is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a prescription medication. The contract has no set-aside designation and is scheduled for completion by April 24, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This federal contract award, valued at $1,315.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of QUILLIVANT XR 25 MG/5 ML SUSP 120ML. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including...